Clinical Trial Update: Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol [Phase 2]

View source ↗

Summary

This entry covers a Phase 2 clinical trial of QLC7401 for primary hypercholesterolemia or mixed hyperlipidemia with elevated LDL, which is not recruiting yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• QLC7401

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 2 | Status: NOT_YET_RECRUITING